Skip to main content
Premium Trial:

Request an Annual Quote

Curi Bio Acquires Artificial Intelligence Firm Dana Solutions

NEW YORK — Curi Bio said on Thursday that it has acquired Dana Solutions, a Palo Alto, California-based developer of artificial intelligence (AI) technologies for in vitro cell-based assays.

Curi offers a range of induced pluripotent stem cell (iPSC)-based products for drug discovery including its Car(ina) cardiac microtissue model, as well as its NanoSurface Plate line of microplates.

Through the acquisition, Curi will gain Dana's portfolio of AI and machine learning (ML) platforms, which include PhenoLearn for cell and tissue phenotype modeling, Pulse for contractility analysis of beating cardiomyocytes, and PhenoTox for predictive safety pharmacology.

"We are building best-in-class models of human diseases using human iPSC-derived cells and physiologically-relevant biosystems," Curi CSO Nicholas Geisse said in a statement. "With Dana's deep learning tools, now we can apply AI/ML-based phenotypic screening to our models to detect patterns in multidimensional phenotypic data at scale."

Curi, based in Seattle, said that it will continue Dana's US Food and Drug Administration-funded alliance with the Health and Environmental Sciences Institute to validate PhenoTox for the predictive assessment of drug-induced structural cardiac toxicity. Dana's software-as-a-service platforms will continue to operate until the expiration of existing customer contracts.

Additional terms of the acquisition were not disclosed.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.